Latest Oxycodone Stories
RICHMOND, Va., May 8, 2014 /PRNewswire-iReach/ -- Dr.
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Patent Protection for KP511 Extends KemPharm's Intellectual Property Estate for Leading Franchise of Abuse-Deterrent Opioid Medications CORALVILLE, Iowa, April 30, 2014 /PRNewswire/
WAYNE, Pa., April 29, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its first quarter financial results will be released on Tuesday, May 13, 2014.
SYDNEY and BEDMINSTER, N.J., April 22, 2014 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) Anesthetic and Analgesic
DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/lzqfh9/drugs_of_abuse) has announced the addition of the "Drugs
Continued dialogue needed to make a tangible difference OTTAWA, April 15, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, reaffirmed her commitment to tackle the
SAN DIEGO, April 11, 2014 /PRNewswire/ -- Rampant misinformation about Zohydro(TM) ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals.
Management to Detail the Commercialization of High Value Pain Products including Oxycodone using its TPM® Topical Drug Delivery Technology MELBOURNE, Australia, March 26,
WAYNE, Penn., March 13, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its fourth quarter and year ended December 31, 2013 financial results will be released